This page contains regularly updated information on Realm Therapeutics securities and the Company's most significant shareholders. Realm Therapeutics is traded on Nasdaq. There are no restrictions on the trading of Realm Therapeutics' shares

As of 28 May 2019
Number of securities in issue: 116,561,917 10p Ords
There are no shares held in treasury.
Percentage of Securities not in public hands: 35.62%

As of 28 May 2019, the following shareholders held interests in excess of 3% of ordinary share capital.

  
  Amount % Holding
OrbiMed 25,537,109 21.91%
BVF Partners LP 22,744,016 19.15%
BAVARIA Industries Group AG 6,944,948 5.96%
Sussex Trading Company Limited 6,148,880 5.28%
Daniel Hegglin 5,849,091 5.02%
Oracle Management Limited 5,410,196 4.64%
Kanton Services Limited 4,629,196 3.97%
Polar Capital Funds Plc 3,500,000 3.00%
     

Directors' Information

  Amount % Holding
Mr. Spicer 273,930 0.24%
Mr. Martin* 248,115 0.21%
Ms. Thorell* 50,000 0.04%
Dr. Gill - 0.00%
Mr. Zweifach - 0.00%

* Executive Director

Search Investor Relations